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Abstract
Background: Hemophagocytic lymphohistiocytosis (HLH) is a fatal clinical syndrome characterized by excessive
immune activation and inflammation. It is frequently complicated by acute kidney injury (AKI) that often develops
as acute tubular necrosis (ATN). Meanwhile, renal thrombotic microangiopathy (TMA) is a rare pathologic finding
that mostly occurs in hemolytic uremic syndrome or thrombotic thrombocytopenic purpura. There are only few
reports on TMA developing in patients with HLH. We present here a rare case of TMA associated HLH.
Case presentation: A 60-year-old woman was admitted for a fever of unknown origin that had persisted for several
weeks. She presented with AKI and pancytopenia. Clinical, laboratory and bone marrow biopsy findings met the criteria
of HLH. Kidney biopsy showed TMA and minimal ATN, which suggested that the primary cause of AKI was TMA in this
case. Because of sustained oliguria, we initiated hemodialysis (HD) and also decided to use chemotherapy composed
of dexamethasone, etoposide and cyclosporine for treatment of HLH. Six months after the initiation of chemotherapy,
pancytopenia was completely resolved, indicating the resolution of HLH. At the same time, serum creatinine decreased
to a normal range without the need for HD, suggesting the resolution of TMA.
Conclusion: We report a case of renal TMA associated HLH. This case suggests that renal TMA should be considered as
a primary cause of AKI in patients with underlying HLH.
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Background
Hemophagocytic lymphohistiocytosis (HLH) is a very
rare clinical syndrome characterized by excessive im-
mune activation and inflammation [1–3]. Severe HLH
is commonly accompanied by various organ dysfunc-
tions including manifestation of acute kidney injury
(AKI). Indeed, the prevalence of AKI in severe HLH
has been reported as 30 ~ 50 %, and acute tubular ne-
crosis (ATN) by sepsis or dehydration due to fever has
been suspected as the renal pathology in HLH with
AKI [1, 2, 4]. Meanwhile, thrombotic microangiopathy
(TMA) is rarely detected in the renal pathology state,
which develops secondary to hematologic, autoimmune or
infectious disease. Hemolytic uremic syndrome (HUS) or
thrombotic thrombocytopenic purpura (TTP) is a well
characterized disorder associated with TMA [5, 6]. How-
ever, TMA is rarely detected in patients with HLH, despite
the frequent development of renal complications.
In the present case, we encountered AKI developed as
TMA in a patient diagnosed with HLH. We successfully
treated both the TMA and HLH using cytotoxic therapy
including dexamethasone, etoposide and cyclosporine.
Case presentation
A 60-year-old woman was admitted because of persist-
ent fever of unknown origin lasting for several days. She
had been in a good state of health prior to admission
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and had no specific underlying disease. She had no re-
lated family history and medication history. Upon phys-
ical examination, the vital signs were as follows: blood
pressure, 120/80 mmHg; pulse rate, 87 beats per minute;
and body temperature, 37.8 °C. There were no palpable
lymph nodes in the neck, armpit and groin areas. Both
legs had pitting edema and petechial rashes. She also
complained of diffuse abdominal pain and oliguria that
had been present for several days.
Laboratory findings are summarized in Fig. 1. Pancyto-
penia (white blood cell count, 2750/μL; hemoglobin,
8 g/dL; platelet count, 63,000 /μL) was detected and serum
creatinine level was significantly elevated (4.59 mg/dL).
Serum ferritin, C-reactive protein and lactate dehydrogen-
ase were increased as well. Prothrombin times (PT),
activated partial thromboplastin times (aPTT) and fibrino-
gen were within normal limits. There was no dyslipidemia,
including hypertriglyceridemia. The patient’s soluble
interleukin-2 receptor level in serum was 5.2 % (normal
range 5–30 %) and natural killer (NK) cells activity was
decreased (NK cells activity, 3.7 %; normal range 6–29 %).
Urinary protein/creatinine ratio was 906.4 mg/g. Periph-
eral blood smear showed normocytic normochromic
anemia and thrombocytopenia. The examination revealed
no schistocytes and anisocytosis, which suggested absence
of microangiopathic hemolytic anemia (MAHA). Abdom-
inal computerized tomography (CT) scan for the evalu-
ation of abdominal pain showed no abnormal findings for
the bowel, pancreas or the biliary tract. Both kidney sizes
were normal without chronic change, but there was sig-
nificant splenomegaly, multifocal ascites and pleural effu-
sion were detected.
At first, we used broad-spectrum antibiotics for neutro-
penic fever and initiated hemodialysis for acute renal fail-
ure. However, we did not find any etiology for neutropenic
fever from urine or blood culture studies. In addition,
virus studies, including epstein-barr virus, parvovirus B19,
adenovirus, human immunodeficiency virus, hepatitis B
and influenza virus were negative on serologic tests. Anti-
hepatitis C virus antibody was positive but alanine trans-
aminase and aspartate transaminase levels were normal,
which suggested that hepatitis C virus was in an inactive
state. The patient showed no evidence of tuberculosis in
chest X-ray, sputum acid-fast bacillus (AFB) stain and
AFB culture, sputum and urine tuberculosis polymerase
chain reaction. Autoimmune disorders such as systemic
lupus erythematosus or rheumatoid arthritis were carefully
ruled out by clinical symptoms and signs and by autoanti-
body tests.
Consequently, we decided to perform a bone marrow
(BM) biopsy to determine the reason for fever and pan-
cytopenia. BM biopsy revealed about 10 % cellularity
and numerous histiocytes with engulfed lymphocytes,
polymorphonuclear and red blood cells, which were
suggestive of hemophagocytosis (Fig. 2). Finally, the
patient was diagnosed with HLH based on fever, pro-
gressive pancytopenia, hyperferritinemia, splenomegaly,
decreased NK cell activity and hemophagocytosis in
Fig. 1 Clinical course and laboratory findings of the patient
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BM and negative results on viral and autoimmune
marker studies.
Meanwhile, a kidney biopsy was performed to investi-
gate the cause of acute kidney injury because renal func-
tion did not improve. PT times (PT INR, 1.13) and aPTT
times (aPTT, 23.3 seconds) were within normal limits. But
complete blood count showed thrombocytopenia. We
used prophylactic transfusion of platelets in preparation
for a kidney biopsy that could cause bleeding. Under light
microscopic examination, glomeruli were slightly enlarged
with hypercellularity involving mesangial and endothelial
cells. Capillary lumens were frequently filled with frag-
mented red blood cells and platelet aggregates (Fig. 3a).
Tubules revealed focal moderate atrophy and loss with
interstitial fibrosis (Fig. 3b). In an immunofluorescence
study, staining for immunoglobulin G, immunoglobulin
M, immunoglobulin A, C4, fibrinogen, kappa and lambda
were negative. In electron microscopy, no electron-dense
deposits were found and epithelial foot process showed
focal marked effacement (Fig. 3c). The above histologic
findings were compatible with renal TMA.
At this time, we planned 6 cycles of cytotoxic therapy
comprised of dexamethasone, etoposide at 100 mg/m2
and cyclosporine at 200 mg/day for the treatment of HLH
based on the HLH-2004 protocol [7]. Dexamethasone
started at 10 mg/ m2 for 2 weeks, and then reduced to
50 % of initial dose every 2 weeks. As etoposide is cleared
by both renal and hepatic routes, dose adjustment of eto-
poside based on renal function is recommended for the
HLH-2004 protocol. We started at etoposide 100 mg/m2
with dose reductions of 25 % based on the patient’s renal
function. The general condition of the patient gradually
improved and the fever subsided 7 days after the initiation
of cytotoxic therapy. Concomitantly, urine output also in-
creased and we ceased hemodialysis at 28 days from the
first initiation of hemodialysis. After the 4th cycle of eto-
poside treatment, she suffered neutropenic fever due to
vancomycin-resistant enterococci infection, which was
successfully treated with linezolid and recombinant hu-
man granulocyte colony stimulating factor. After 7 cycles
of etoposide treatment, she was discharged with normal
Fig. 2 Bone marrow biopsy findings. Microscopic findings of bone





Fig. 3 Kidney biopsy findings. a Light microscopic findings show
capillary lumens filled with fragmented red blood cells and platelet
aggregates (H&E stain, ×400). b Light microscopic findings show
tubules reveal focal moderate atrophy and loss with interstitial fibrosis
(H&E stain, ×200). c Electron microscopy findings show focal effacement
of podocyte foot processes. There are no electron-dense deposits
(Original magnification, ×5000)
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kidney function and no signs of fever or neutropenia. At
6 months after the initial presentation, she showed no
signs of HLH recurrence. A bone marrow aspiration and
biopsy was done and the bone marrow biopsy looked nor-
mal cellular with normal hematopoiesis. Her serum cre-
atinine level were in the normal range (0.99 mg/dL).
Discussion
In this report, we describe a patient admitted for persist-
ent fever, edema and abdominal discomfort. She also
complained of oliguria for the past several days. Labora-
tory findings showed pancytopenia combined with AKI.
The cause of the neutropenic fever was diagnosed as
HLH and the cause of the acute renal failure was renal
TMA. Cytotoxic therapy targeting HLH improved both
neutropenic fever and AKI, suggesting that TMA may
have developed secondary to HLH.
With regard to the neutropenic fever, we concluded that
a severe bacterial infection might have been the main
cause. Therefore, we also suspected that AKI might have
developed, as associated with the infection and volume de-
pletion due to fever and poor oral intake over the past few
days. Contrast dye used for abdominal CT could have con-
tributed to the aggravation of acute kidney injury. However,
we could not find any evidence of infection in the blood,
urine culture study, and radiologic exam. In addition, broad
spectrum antibiotics did not improve pancytopenia even
though the fever partially subsided. In addition, renal func-
tion did not improve with fluid therapy and sustained
hemodialysis. As a result, we decided to perform kidney
biopsy for acute kidney injury of unknown origin and bone
marrow biopsy for fever of unknown origin as well. Kidney
biopsy showed pathologic findings compatible with TMA.
ATN, which is the main finding in cases of infection associ-
ated with AKI or pre-renal AKI, was minimal. This
suggested that the primary cause of AKI in this case was
not pre-renal or infection-associated AKI but TMA. Inter-
estingly, bone marrow biopsy revealed active hemophago-
cytosis. From the physical exam, radiologic findings and
laboratory findings such as fever, progressive pancytopenia,
hyperferritinemia, and splenomegaly, we diagnosed HLH in
this patient.
Renal TMA frequently manifests as AKI in nearly
90 % of the cases [8]. This disease entity describes a
pathological process of microvascular thrombosis due
to endothelial injury. Usually, it results from HUS, TTP
or malignant hypertension, all of which may induce sig-
nificant endothelial injury in microvasculature [5, 6, 8].
Her laboratory findings showed that MAHA was nega-
tive and the stool study for E.coli O157:H7 as well as
the streptococcus pneumonia urinary antigen test were
negative. The patient’s blood pressure was normal and
clotting parameters were within normal limits as well.
Therefore, we could rule out HUS, atypical HUS, TTP,
disseminated intravascular coagulation and malignant
hypertension for the etiology of renal TMA.
Our next consideration was whether the development
of TMA was related to underlying HLH. Acute kidney
injury is frequent in severe HLH cases and results from in-
flammatory or ischemic lesions of the renal tubules [2, 9].
The most frequent presentation of renal damage in HLH
is ATN [2, 4, 10]. Some authors have described intrarenal
lesions associated with hemophagocytosis [11]. Nephrotic
syndrome can also occur but seems to be less common
than ATN and collapsing glomerulopathy, minimal-
change disease and focal segmental glomerulosclerosis
with marked podocytosis have been reported [2, 4, 12].
Vascular lesions have been also reported and in a few
reports it was a feature of TMA [4, 13].
Clinical features in renal TMA in HLH patients are
summarized in Table 1. AKI was present in 5/5 cases and
oliguria in 2/5 cases. Proteinuria and microscopic
hematuria was present in 5/5 and 4/5 cases, respectively.
Our case showed generalized edema, proteinuria and
hematuria compatible with nephritic syndrome. Nephritic
syndrome associated with renal TMA in HLH is more
frequent than nephrotic syndrome. Dialysis therapy was
required for two patients. Four patients recovered and
death occurred in one case.
Pathogenesis of HLH could explain the development of
TMA. The release of large amounts of tumor necrosis
factor (TNF), an important inflammatory cytokine, by
activated macrophages was detected during the acute
phase of HLH [4, 14]. Renal endothelial cells are activated
by TNF and acute endothelial cell changes may lead to
altered vascular reactivity, permeability, adherence of
leukocytes, coagulation and microvascular vasomotor
autoregulation [8, 14, 15]. Therefore, we postulate that
these inflammatory processes may cause severe vascular
endothelial cell injury and then induce platelet adhesion on
its surface for the initial event of platelet aggregates [8, 15].
Nevertheless, TMA in HLH has been rarely reported
maybe because diagnostic biopsy has been rarely done in
HLH patients. Hence it is possible that TMA in HLH may
occur with greater frequency than previously known.
After the diagnosis of HLH, we decided to perform
cytotoxic therapy targeting HLH. The therapy was based
on the HLH-2004 protocol, which was comprised of a
cocktail of etoposide, dexamethasone, and cyclosporine
[16, 17]. After the treatment, pancytopenia resistant to
broad spectrum antibiotics and conservative therapies im-
proved. In addition, renal function gradually improved,
and serum creatinine level decreased to a normal range
after 6 cycles of the cytotoxic therapy. As we mentioned
above, we thought the cause of TMA was HLH; hence it
is possible that the therapies applied in this case effectively
controlled cytokine burst and blocked vascular endothelial
cell injury, resulting not only in the improvement of
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symptoms related to HLH, but also in the improvement of
AKI associated with renal TMA.
Conclusions
In this case, we report TMA associated HLH which was
successfully treated with cytotoxic therapy targeting
HLH. This case suggests that for acute kidney injury in
patients with underlying HLH, underlying renal TMA
may be considered as the cause of AKI.
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